Zurit Levine
Chief Tech/Sci/R&D Officer at COMPUGEN LTD.
Profile
Zurit Levine is currently the Vice President-Technology Innovation at Compugen Ltd.
Prior to this role, Dr. Levine held positions as Director at Neviah Genomics Ltd.
and Therapeutic Discovery Corp.
Dr. Levine has an educational background that includes undergraduate, graduate, and doctorate degrees from Tel-Aviv University.
Zurit Levine active positions
| Companies | Position | Start |
|---|---|---|
| COMPUGEN LTD. | Chief Tech/Sci/R&D Officer | 2017-12-31 |
Former positions of Zurit Levine
| Companies | Position | End |
|---|---|---|
Therapeutic Discovery Corp.
 Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Director/Board Member | 2006-12-31 |
Neviah Genomics Ltd.
 Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Director/Board Member | - |
Training of Zurit Levine
| Tel-Aviv University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Therapeutic Discovery Corp.
Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Health Technology |
Neviah Genomics Ltd.
Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Health Technology |
- Stock Market
- Insiders
- Zurit Levine
